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Abstract 
The Na+-taurocholate cotransporting polypeptide (NTCP) mediates uptake of 
conjugated bile acids (BAs) and is localized at the basolateral membrane of 
hepatocytes. NTCP has recently been recognized as the receptor mediating 
hepatocyte-specific entry of Hepatitis B (HBV) and Hepatitis Delta viruses 
(HDV). Myrcludex B, a peptidic inhibitor of HBV entry, is assumed to 
specifically target NTCP. Here, we investigated BA transport and Myrcludex B 
binding in the first Slc10a1-knockout mouse model (Slc10a1 encodes NTCP). 
Primary Slc10a1-/- hepatocytes showed absence of sodium-dependent 
taurocholic acid (TCA) uptake, whereas sodium-independent TCA uptake was 
unchanged. In vivo, this presented as a decreased serum BA clearance in all 
knockout mice. In a subset of mice, NTCP deficiency resulted in markedly 
elevated total serum BA concentrations, mainly composed of conjugated BAs. 
The hypercholanemic phenotype was rapidly triggered by a diet 
supplemented with UDCA. Biliary BA output remained intact, while fecal BA 
excretion was reduced in hypercholanemic Slc10a1-/- mice, explained by 
increased Asbt and Ostα/β expression. These mice further showed reduced 
Asbt expression in kidney and increased renal BA excretion. Hepatic uptake 
of conjugated BAs was potentially affected by downregulation of OATP1A1 
and upregulation of OATP1A4. Furthermore, sodium-dependent TCA uptake 
was inhibited by Myrcludex B in wild-type hepatocytes, while Slc10a1-/- 
hepatocytes were insensitive to Myrcludex B. Finally, positron emission 
tomography showed a complete abrogation of hepatic binding of labelled 
Myrcludex B in Slc10a1-/- mice. 
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Conclusion: The Slc10a1-knockout mouse model supports the central role of 
NTCP in hepatic uptake of conjugated BAs and HBV preS1/Myrcludex B 
binding in vivo. The NTCP-independent hepatic BA uptake machinery 
maintains a (slower) enterohepatic circulation of BAs, although it is 
occasionally insufficient to clear the circulation from BAs. 
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During and after a meal, BAs are released into the small intestine, where they 
facilitate the absorption of dietary fat and fat-soluble vitamins (1). The majority 
of BAs are reabsorbed in the terminal ileum and transported back to the liver 
via the portal circulation. At the basolateral membranes of the hepatocytes, 
BAs are taken up from the portal circulation, are extruded across the 
canalicular hepatocyte membrane and transported to the gallbladder to 
complete the enterohepatic circulation (2). Conjugated BAs are transported 
across the basolateral hepatic membrane via a sodium-dependent pathway, 
mainly mediated by the sodium taurocholate cotransporting polypeptide 
(NTCP; gene name SLC10A1) (3, 4), and a sodium-independent pathway. 
The latter is likely mediated by members of the organic anion transporter 
superfamily (OATPs), which are also responsible for the hepatocellular uptake 
of unconjugated BAs (5, 6). NTCP is a liver-specific dimeric transmembrane 
glycoprotein (7) responsible for the majority of glycine/taurine-conjugated BA 
uptake in primary hepatocytes (4). Besides its role in BA homeostasis, NTCP 
is able to transport sulphated steroids, thyroid hormones and xenobiotics (8, 
9). Reducing hepatocellular BA uptake is considered as a hepatic defence 
mechanism to prevent accumulation of potentially toxic BAs within 
hepatocytes. NTCP is regulated at the transcriptional level by cellular 
signalling pathways directly or indirectly involving farnesoid X receptor (FXR) 
and small heterodimer partner (SHP) (10). NTCP is strongly downregulated in 
conditions that could lead to hepatocellular BA overload, such as cholestasis 
(11). Recently, interest in NTCP activity and regulation and its contribution to 
BA homeostasis was boosted immensely when Li and co-workers identified 
NTCP as the functional cellular receptor permitting HBV and HDV to enter 
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primary human liver cells (12). Their findings were confirmed by others (13), 
who showed that HBV binding to NTCP is mediated by the myristoylated 
preS1-domain of the HBV large surface (L)-protein (14). NTCP-mediated virus 
entry is blocked by Myrcludex B, a synthetic preS1-lipopeptide derived from 
the HBV L-protein (15). The consequences of prolonged inhibition of NTCP-
mediated BA transport in vivo are unknown. This is important to investigate, 
since Myrcludex B inhibits NTCP-mediated BA uptake at high concentrations 
(13). Here, we describe the first genetic knockout mouse model to study the 
consequences of prolonged and complete absence of NTCP. Our findings 
underscore that NTCP plays a pivotal role in hepatic uptake of conjugated 
BAs in vivo and is a crucial receptor for the myristoylated preS1-domain of the 
HBV L-protein. 
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Materials & methods 
More detailed information about quantification of BAs, hepatocyte culture and 
TCA uptake in vitro, BA dynamics in vivo, Myrcludex imaging and on the 
methods described below is provided in the Supplementary Information. 
 
Gene-targeting strategy and generation of Slc10a1-/- mice 
Mice heterozygously lacking exon 1 of Slc10a1 were generated by Lexicon 
Genetics Incorporated (The Woodlands, Texas, US), and obtained via 
Taconic (Hudson, NY, US). Detailed information on gene-targeting (Figure 
1A) and mouse housing and feeding is provided as Supplementary 
Information. The study design and all protocols for animal care and handling 
were approved by the Institutional Animal Care and Use Committee of the 
University of Amsterdam.  
 
RNA isolation, qRT-PCR and Western Blot analysis 
Total RNA was isolated with TRIzol reagent (Invitrogen, Bleiswijk, The 
Netherlands). cDNA was synthesized from DNAse-treated total RNA with 
Oligo-dT12-18 and Superscript II reverse transcriptase (Invitrogen). Quantitative 
real-time PCR (qRT-PCR) was carried out in a Roche Lightcycler 480 II 
instrument using SensiFAST SYBR No-ROX kit (Bioline, UK). Expression 
levels in each sample were normalized for the geometrical mean of two 
reference genes (Supplementary Information). Crude mouse liver membranes 
were isolated by ultracentrifugation and the pellets were resuspended in RIPA 
buffer (50 mM Tris-HCl pH 8.0, 150 mM NaCl, 1% (v/v) NP-40, 0.5% (w/v) Na-
deoxycholate, 0.1% (w/v) SDS). Membrane proteins were separated on a 
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10% SDS-polyacrylamide electrophoresis gel, transferred to nitrocellulose and 
probed with primary antibodies as described in the Supplementary 
Information. Equal loading was ensured by reprobing the membrane with an 
anti-sodium/potassium ATPase antibody (kind gift of J. Koenderink, Nijmegen, 
the Netherlands) or with an anti-β-actin antibody (Abcam; ab8226).  
 
Bile secretion and TCA elimination in vivo 
Bile secretion in fasted Slc10a1-/- mice was investigated by performing gall 
bladder cannulation and bile collection for 30 minutes after distal ligation of 
the common bile duct (16). Bile flow was determined gravimetrically assuming 
a density of 1 g/mL for bile. Bile output was calculated as the product of the 
bile flow and the bile concentration in the second 10-minute collection period. 
After the 30 minutes depletion-phase, a single bolus of 150 µmol TCA / kg 
mouse (including a trace amount of tritium-labelled TCA) was administered 
intravenously in the tail vein in 100 µL 0.9% NaCl per 20 g mouse. A heating 
pad maintained body temperature at 37 °C. Blood samples (~30 µL) were 
collected 30 minutes before TCA administration and both blood and bile were 
collected at the indicated time points after TCA administration. Radioactivity in 
serum and bile was measured by liquid scintillation counting, and values are 
shown as a percentage of the total bolus (=100%). 
 
Peptide synthesis, 68Ga-labelling and PET-imaging 
Myrcludex B-derived myristoylated HBV preS1 peptides were synthesized on 
a solid phase matrix using fluorenylmethoxycarbonyl/t-butyl (Fmoc/tBu) 
chemistry, as previously described (17). A full description of Myrcludex B 
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synthesis is provided in the Supplementary Information. Peptides are depicted 
schematically in supplementary figure 4. For 68Ga-labelling, 1000 µl 
[68Ga]Ga3+ eluate, 20 µl of a 1 mM peptide solution in DMSO, 10 µl ascorbic 
acid solution (20% in H2O) and 295 µl 2.5 M sodium acetate were mixed (pH 
3.6) and heated at 90 °C for 15 minutes. The labelled peptide was purified 
using solid phase extraction (Thermo Scientific, Schwerte, Germany), eluted 
(ethanol), dried, dissolved in 60 µl DMSO and 240 µl of 0.9% NaCl was 
added. Mice were anesthetized with 1% sevoflurane (Abbott, Wiesbaden, 
Germany) and placed into an Inveon small animal PET scanner (Siemens, 
Knoxville, US). Investigators were blinded to mouse genotypes. A dynamic 
microPET was performed up to 60 min post-injection with 68Ga-labelled 
peptides (6 to 27 MBq/animal in a 100 µl peptide solution in a tail vein).  
 
Statistical analysis 
Data are provided as the mean ± standard error of the mean. Differences 
between groups were analysed using 2-tailed Student’s t-test. For serum and 
bile kinetics, half-time (t½) and one-phase decay curves were calculated using 
Graphpad Prism 5. Statistical significance was considered at p<0.05. 
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Results 
Generation of NTCP-deficient mice by targeted knockout of the Slc10a1 
gene 
Homologous recombination leading to the deletion of exon 1 in the Slc10a1 
locus (figure 1A) on chromosome 12, with replacement of a β-
galactosidase/puromycin resistance gene cassette in embryonic stem cells 
and generation of heterozygous knockout animals was performed by Lexicon. 
NTCP-deficient offspring showed normal Mendelian frequency and viability. 
They were fertile and showed no obvious anatomic abnormalities. PCR 
analysis identified the expected recombination by revealing the Slc10a1 wild-
type (412-bp) and targeted (624-bp) alleles in both male and female mice 
(figure 1B; primers are shown in supplementary table 1). Analysis of liver RNA 
revealed that the Slc10a1 mRNA was totally absent in the knockout mice, and 
was reduced to 39.9 ± 8.7% and 43.1 ± 6.4% in male and female 
heterozygous mice, respectively, compared to wild-type mice (figure 1C). This 
suggests a lack of transcripts or an unstable Slc10a1 product in knockout 
mice. Note that the primers encompass exon 4 of Slc10a1, which is not 
targeted by homologous recombination (see supplementary table 2). 
Furthermore, a glycosylated form of NTCP (~45-50 kDa; supplementary figure 
1B) was detected in the liver homogenates of wild-type mice (n=3), but was 
undetectable in knockout mice, as shown by Western blot analysis (figure 
1D). In heterozygous mice, the NTCP protein expression was approximately 
90 ± 30% of the levels observed in wild-type mice (supplementary figure 1A), 
explaining the absence of any apparent phenotypic changes in those mice. 
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Lack of NTCP signal in immunofluorescent stainings of mouse liver confirmed 
the null phenotype (figure 1E). 
 
Diminished TCA uptake and extremely high taurine-conjugated serum 
BA concentrations in adult Slc10a1-/- mice 
To assess whether Slc10a1-/- mice lose sodium-dependent BA uptake, TCA 
transport was assessed in sandwich cultured primary mouse hepatocytes 
(PMHs) from wild-type and Slc10a1-/- mice. Since Slc10a1 expression is 
rapidly downregulated in primary hepatocyte cultures (18, 19), the TCA 
uptake assay was performed 3 hours after PMH seeding. Uptake increases in 
a linear fashion within at least 60 seconds (data not shown). Sodium-
dependent TCA uptake of wild-type PMH was 66.0 ± 7.1 pmol/min, which 
decreased to 29.2 ± 1.7 pmol/min following replacement of Na+ with NMDG 
(Figure 2A). This sodium-dependent TCA uptake was completely absent in 
Slc10a1-/- PMHs, which showed similar TCA uptake as wild-type mice under 
sodium-free conditions (24.3 ± 3.6 pmol/min). The presence of 1 µM 
Myrcludex B abrogated sodium-dependent TCA uptake in wild-type PMHs, as 
shown previously (13), but had no effect on TCA uptake under sodium-free 
conditions. In Slc10a1-/- PMHs, TCA uptake remained at similar levels in the 
sodium-dependent as well as sodium-free conditions, and this was unaffected 
by the addition of 1 µM Myrcludex B. 
 
To investigate whether NTCP affects BA homeostasis, total serum BA 
concentrations and different BA species were measured in wild-type and 
Slc10a1-/- mice fed a standard diet. A subpopulation of NTCP-deficient mice 
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had significantly elevated total serum BA levels, reaching millimolar 
concentrations (figure 2B). No obvious gender differences were observed for 
this phenotype. Total serum BA levels were in the normal range for both wild-
type and heterozygous mice (range 1-21 µmol/L), and only wild-type mice 
were used for further comparisons. Notably, the majority of Slc10a1-/- mice 
(60-75%) had normal serum BA concentrations, despite complete lack of 
NTCP protein. Hypercholanemia during NTCP deficiency was defined as total 
serum BA levels >20 µmol/L. Both hypercholanemia and normocholanemia in 
Slc10a1-/- mice were preserved during the backcross to C57Bl/6J (from 50% 
genetically similar to 129/SvEv to >98% similar to C57Bl/6J), excluding effects 
of different mouse strain backgrounds. Next, the serum concentrations of 
individual BA species was determined by HPLC. Slc10a1-/- mice with high 
serum BA concentrations had significant increases in taurocholic acid (TCA), 
tauro-α-muricholic acid (TαMCA) and tauro-β-muricholic acid (TβMCA) (figure 
2C), which were 1673 ± 840.1 µmol/L, 107.9 ± 63.1 and 439.8 ± 214.3 µmol/L, 
respectively. NTCP deficiency caused a relative mild increase in 
unconjugated BAs, only in mice with high serum BA concentrations, which 
was caused by an increase of deoxycholic acid to 87.4 ± 65.3 µmol/L (figure 
2D). Glycine-conjugated species were below the detection limit (0.125 µmol/L) 
in all mice, thus they were not included in our results. Slc10a1-/- mice with high 
serum BA concentrations have a shift towards increased conjugated BA 
species (87 ± 12% of total; as to 59.8 ± 12% in wild-type mice) (figure 2E), 
whereas this shift was not observed in Slc10a1-/- mice with physiological BA 
concentrations (51.7 ± 10% of total). 
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Phenotype characteristics of Slc10a1-/- mice  
Heterozygous mice carrying one intact Slc10a1 allele were indistinguishable 
from wild-type littermates. Slc10a1-/- mice were phenotypically very similar to 
their littermates, except that the mice (in both the male and female group) had 
reduced body weights directly post-weaning (day 21) compared to littermates 
and this difference was also present at 2 months of age (table 1). The body 
weights were inversely correlated with total serum BA levels (figure 2F), and 
the hypercholanemic knockout mice had a strongly reduced body weight. 
Liver morphology appeared macroscopically normal, and the ratios of liver 
weight to body weight were unaffected. Serum concentrations of conjugated 
bilirubin were moderately increased from 2.6 ± 0.6 µmol/L in wild-type mice to 
31.4 ± 8.0 µmol/L in hypercholanemic knockout mice, whereas 
normocholanemic knockout mice did not show any elevations in conjugated 
bilirubin levels. Furthermore, no significant differences were found in 
aspartate transaminase and alanine transaminase between wild-type and 
hypercholanemic Slc10a1-/- mice (supplementary table 3). Alkaline 
phosphatase increased from 22.0 ± 6.2 U/L in wild-type mice to 219.1 ± 38.8 
U/L in hypercholanemic knockout mice. These biochemical values are not 
indicative of extensive hepatobiliary damage as ~10 to 20 times higher serum 
levels of bilirubin and alanine transaminase are detected in severely 
cholestatic rodents, for instance bile duct-ligated mice (20). Examination of 
hematoxylin- and eosin-stained liver sections for all genotypes revealed no 
overt abnormalities. In particular, no signs of cholestasis, inflammation or 
hepatocellular damage were observed in Slc10a1-/- mice (supplementary 
figure 2). 
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Normocholanemic Slc10a1-/- mice fed a 0.1% ursodeoxycholic acid diet 
rapidly develop extremely high serum BA concentrations  
To challenge the hepatic BA uptake machinery during NTCP deficiency, both 
young and adult wild-type and Slc10a1-/- mice were fed for 4 to 8 days with 
0.1% UDCA, with the rationale to increase the amount of BAs reaching the 
portal circulation that need to be handled by the liver. Under this condition, 
young Slc10a1-/- mice showed extremely high serum BA levels, which was 
attributed to a significant increase in conjugated BAs, mainly TCA and TβMCA 
(figure 3A), but also unconjugated species tended to be elevated in a subset 
of mice (figure 3B). Experiments were repeated with adult mice, and BA levels 
were measured before start of UDCA-supplementation. After 1 week of 0.1% 
UDCA-supplementation, total serum BA concentrations in adult Slc10a1-/- 
mice significantly increased from 514.4 ± 309.1 µmol/L to 2528 ± 792.7; 
versus 3.4 ± 1.4 µmol/L in wild-type mice fed UCDA (figure 3C). Two knockout 
mice could not be forced into hypercholanemia post-UDCA-supplementation, 
having comparable BA levels as wild-type mice. Two out of eight Slc10a1-/- 
mice were already hypercholanemic pre-UDCA-supplementation and 
remained extremely hypercholanemic. These findings suggest that the NTCP-
independent hepatic BA uptake machinery operates close to its maximum 
capacity in Slc10a1-/- mice and can easily be saturated. 
 
Delayed serum TCA elimination and biliary excretion in Slc10a1-/- mice  
To examine the contribution of NTCP to (conjugated) BA kinetics in vivo, we 
investigated the clearance of conjugated BAs from serum into bile by 
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intravenous administration of TCA in wild-type and both normocholanemic 
and hypercholanemic Slc10a1-/- mice. Serum TCA elimination half-time 
significantly increased from 1.5-minutes (CI 1.2 ± 2.3) in wild-type to 5.3-
minutes (CI 3.9 ± 7.9) in normocholanemic Slc10a1-/- mice (figure 4A). Also, 
biliary excretion of TCA was evidently delayed in normocholanemic Slc10a1-/- 
mice compared to wild-type mice (figure 4B). The high-dose of TCA proved to 
be lethal in hypercholanemic Slc10a1-/- mice shortly after injection. To assess 
systemic BA clearance during hypercholanemia, total serum BA 
concentrations were determined in time in these mice after gall bladder 
cannulation, without prior TCA administration. We observed a markedly 
delayed serum BA clearance (t½ >40 min; figure 4C).  
 
Biliary, fecal and renal BA excretion during NTCP deficiency 
General BA excretion during NTCP deficiency was investigated by collecting  
bile during a 30-minute period. At every time point after gall bladder 
cannulation, no significant changes in bile flow were observed between wild-
type and normocholanemic Slc10a1-/- mice (figure 5A), while hypercholanemic 
Slc10a1-/- mice showed a trend towards slightly decreased bile flow (p=0.38). 
Biliary excretion of BAs was determined in the second 10-minute period after 
gall bladder cannulation, and no significant differences were measured 
between wild-type mice, normocholanemic and hypercholanemic Slc10a1-/- 
mice (figure 5B). Hence, biliary excretion of BAs appears unaffected by NTCP 
deficiency. 
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To gain insight into BA excretion routes during NTCP deficiency, fecal and 
urinary BA levels were measured, together with ileal and renal mRNA 
expression of major BA transporters. Total fecal BA excretion significantly 
decreased to 0.6 ± 0.1 µmol/day/100g BW during hypercholanemia (figure 
5C) compared to 2.8 ± 0.9 and 3.0 ± 0.8 µmol/day/100g BW in wild-type and 
normocholanemic Slc10a1-/- mice. Decreased fecal BA excretion 
corresponded with elevated mRNA expression of ileal Asbt (p=0.09), Ostα 
and Ostβ (figure 5D). Very high urinary BA concentrations were measured 
during hypercholanemia (figure 5E). Urinary BAs were mainly taurine-
conjugated muricholates and cholate (data not shown). Decreased expression 
of renal Asbt to ~30% of wild-type and normocholanemic mice, corresponded 
with increased renal BA excretion (figure 5F). Notably, renal expression of 
both the basolateral bi-directional BA transporter Ostα/β and the apical BA 
extrusion transporter Mrp2 was significantly increased, suggesting that also 
tubular BA transport towards the lumen might contribute to urinary BA 
excretion. 
 
Hepatic expression of BA-transporting OATP family members 
We investigated whether the basolateral hepatic BA transporters of the OATP 
family (21) or the OSTα/β family compensate for the loss of NTCP, possibly 
explaining the normocholanemia in a subset of the Slc10a1-/- mice by 
restoring (conjugated) BA transport capacity. To this end, hepatic gene 
expression levels of mouse Slco1a1 (Oatp1a1), Slco1a4 (Oatp1a4), Slco1b2 
(Oatp1b2), and Slc51a (Ostα) were analyzed by qRT-PCR (figure 6A). 
Messenger RNA expression levels of all tested Oatp family members were 
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unaffected in normocholanemic Slc10a1-/- mice and Ostα mRNA was 
undetectable in all Slc10a1-/- mice (not shown). During hypercholanemia, 
Oatp1b2 and Oatp1a1 mRNA levels decreased to respectively 36 ± 14% and 
40 ± 11% of wild-type levels, and the relative change was not caused by 
gender differences. On the other hand, Oatp1a4 mRNA significantly increased 
to 189% ± 30%. To determine the gene expression of Oatp family members in 
response to BA supplementation, wild-type and hypercholanemic Slc10a1-/- 
mice were analyzed post-UDCA-supplementation. Oatp family members were 
regulated in the same pattern as during spontaneous hypercholanemia 
(supplementary figure 3). Consistent with the mRNA expression pattern, 
OATP1A1 protein was virtually lost during hypercholanemia, while OATP1A4 
protein was significantly upregulated (in both genders, figure 6B). Notably, 
OATP1A1 (male predominant) and OATP1A4 (female predominant) had 
gender-regulated protein expression levels. In contrast, Oatp1b2 mRNA and 
protein expression did not correlate, as OATP1B2 protein expression 
remained stable during NTCP deficiency. These results were opposite to the 
gene expression levels, suggesting that post-transcriptonal regulation occurs, 
which has been described for Oatp isoforms by Rippin et al (19).  
 
Abrogation of Myrcludex B accumulation in the livers of Slc10a1-/- mice 
We evaluated the distribution of radiolabelled Myrcludex B-derived lipopeptide 
after intravenous injection in wild-type, heterozygous and Slc10a1-/- mice. To 
this end, we developed peptides suitable for PET-imaging containing either 
the Myrcludex B sequence (68Ga-WT peptide) or a mutation in the residues 
required for binding (68Ga-control peptide). The functionality of the peptides 
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for liver targeting was confirmed in wild-type mice (supplementary figure 4). 
As previously shown (22), Myrcludex B-derived peptides specifically enrich in 
the liver of wild-type mice, while mutations in the essential receptor binding 
residues of the peptide lead to a loss of hepatocyte binding. Crucially, livers of 
Slc10a1-/- mice had virtually no accumulation of radiolabelled Myrcludex B 
signal and livers of heterozygous mice have reduced accumulation (60-70% 
compared to wild-type) (figure 7A). The distribution pattern of the 68Ga-WT 
peptide in Slc10a1-/- mice was identical to the pattern observed in wild-type 
mice injected with the 68Ga-control peptide. Within minutes, the WT peptide 
enriched in the liver of wild-type mice, whereas in Slc10a1-/- mice the detected 
signal within the liver remained at a constantly low level, which represents the 
blood flow through the organ (figure 7B; left panel). Non-liver bound peptide in 
Slc10a1-/- mice accumulated in the kidneys (figure 7B; right panel), where it 
was eliminated from the circulation. No gender differences were observed. 
Thus, Slc10a1-/- mice lost the ability to bind Myrcludex B in the liver.  
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Discussion 
The present study shows the first characterization of Slc10a1-knockout mice 
and illustrates the importance of this liver-specific transporter for the hepatic 
uptake of conjugated BAs and as a receptor for Myrcludex B, a synthetic 
preS1-lipopeptide derived from the HBV L-protein. 
 
We describe the consequences of complete and prolonged absence of NTCP 
functionality in vivo. Recently, a 5-year-old patient was described with 
homozygosity for NTCP p.Arg252His, a mutation that strongly affects NTCP 
targeting to the plasma membrane (23). This girl showed persistent 
hypercholanemia without any sign of liver injury or pruritus. Other NTCP 
genetic variants were previously described that result in impaired BA transport 
capacity (e.g. p.Ser267Phe (24)), but no phenotype is yet described to 
associate with these variants. Our data of Slc10a1-/- mice support these 
findings, as 30-35% of the adult mice have markedly elevated total BA levels 
in serum and strongly reduced body weight. In line with the function of NTCP 
as a sodium-dependent transporter of mainly conjugated BAs, these mice 
mainly show serum accumulation of taurine-conjugated BAs. Despite the 
reduced body weights and a strongly reduced capacity to remove conjugated 
BAs from the circulation in Slc10a1-/- mice, no overt liver damage was 
observed. Moderate elevations in serum ALP and bilirubin levels were only 
present in hypercholanemic Slc10a1-/- mice and many Slc10a1-/- mice were 
normocholanemic. This relatively mild phenotype is in line with that of the 
single NTCP-deficient patient described to date. The distribution of the mice 
across these two groups (normocholanemic versus hypercholanemic) 
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persisted over all generations while the mice were backcrossed to C57Bl/6J 
genetic background. We have also observed temporal normalization of the 
serum BA concentration, as well as mature onset of hypercholanemia, further 
excluding mouse genotype/strain effects.  
 
We hypothesize that the sodium-independent hepatic uptake machinery is 
able to sustain the enterohepatic cycle of (conjugated) BAs, but in a subset of 
Slc10a1-/- mice the flux of BAs can (temporarily) exceed the maximum 
capacity of the liver to effectively clear the portal circulation from BAs. In line 
with this hypothesis is our finding that Slc10a1-/- mice accumulate high 
amounts of BAs in the circulation if they are challenged with 0.1% UDCA, and 
this hypercholanemia is inducible in Slc10a1-/- mice with normal or minimally 
elevated serum BA concentrations. Notably, this increase of serum BAs 
included multiple (mostly conjugated) BA species, and not only (T)UDCA, 
which is in line with a saturated uptake machinery. Furthermore, these 
findings suggest that the enterohepatic circulation is still sustained, as UDCA 
is conjugated and also slightly increased levels of unconjugated BAs were 
measured, including CA and DCA. As DCA itself seems to be a poor 
substrate for NTCP (25, 26), increased serum DCA could point to a 
competitive inhibition of the OATP family members by conjugated BAs, 
combined with the loss of OATP1A1 protein. A mild conjugated 
hyperbilirubinemia was observed in hypercholanemic Slc10a1-/- mice, without 
evident cholestatic damage. This observation could support the hypothesis of 
competitive inhibition of OATP isoforms, as the total Oatp1a/1b-knockout 
mouse showed a 40-fold increase of serum conjugated bilirubin (27). 
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The hypercholanemic Slc10a1-/- mice display interesting changes in 
expression of hepatic, ileal and renal BA transporters. Also notable is that  
no changes in Oatp mRNA levels are detected in normocholanemic Slc10a1-/- 
mice, suggesting that compensatory upregulation of these transporters is not 
occurring in NTCP-deficient mice. In line with this finding, in vitro TCA uptake 
of PMHs under sodium-free conditions is similar between wild-type and 
normocholanemic Slc10a1-/- mice. In contrast, Oatp1a1 mRNA and protein 
levels decreased in hypercholanemic Slc10a1-/- mice, whereas Oatp1a4 
mRNA and protein levels slightly increased. Although it is presently unclear if 
the changes in OATP expression are due to or a cause of the 
hypercholanemic phenotype, absence of OATP1A1 could further reduce the 
hepatic uptake capacity for conjugated BAs (5), contributing to the 
hypercholanemia. In contrast, upregulation of OATP1A4 could contribute to 
systemic BA clearance during NTCP deficiency. Fecal BA excretion does 
certainly not provide a likely compensatory mechanism to reduce 
hypercholanemia during NTCP deficiency, considering the enhanced Asbt 
expression and strongly reduced fecal BA excretion. On the other hand, 
enhanced renal BA excretion is the most likely route of BA elimination when 
hepatic BA uptake capacity reaches its maximum, thereby attenuating the 
circulatory BA overload. This could be mechanistically confirmed by a reduced 
renal Asbt expression. Interestingly, renal Ostα/β and Mrp2 mRNA expression 
were increased, possibly allowing excretion of BAs into the ductular lumen, as 
OSTα/β has bi-directional transport properties. This hypothesis as well as the 
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underlying mechanisms for sensing changes in BA dynamics and modulating 
transporter expression will require further investigation. 
 
Recently, NTCP was identified as the receptor for HBV/HDV entry, using a 
proteomic approach to identify proteins that bind the preS1 domain of the 
HBV L-protein (12). This finding could explain many of the characteristics of 
HBV, including its specificity to infect hepatocytes (hepatotropism), as these 
are the only cells that express NTCP. The rapid loss of infectability of primary 
hepatocytes and the total lack of virus binding in virtually all cell lines could 
now be linked to downregulation of NTCP upon isolation of primary cells and 
absence of NTCP expression in all cell lines except differentiated HepaRG 
cells. The myristoylated preS1 subdomain of the HBV L-protein specifically 
binds to the liver in many (also non-HBV-susceptible) animals, including mice 
(22). This exclusive liver targeting makes Myrcludex B a very interesting 
potential drug with high hepatocyte specificity. Using the Slc10a1-knockout 
model, we here show that NTCP is essential for Myrcludex B binding in vivo, 
with a total lack of liver association in Slc10a1-/- mice, indicating that 
association with NTCP mediates the liver-specificity of Myrcludex B and 
supporting a role for NTCP in HBV hepatotropism. 
 
Taken together, this report is the first to describe and characterize a murine 
Slc10a1-knockout model in order to better understand the physiological 
relevance of this BA transporter. Data presented in this study show the 
importance of NTCP for sodium-dependent hepatic BA uptake in vivo and for 
hepatic binding of Myrcludex B, a peptidic inhibitor of HBV entry.  
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Legends 
Figure 1: (a) Conventional knockout of Slc10a1 in mouse ES cells by 
homologous recombination. A schematic representation of the mouse 
Slc10a1 gene. Exon 1 was replaced by the β-galactosidase/puromycin 
(βgeo/puro) selection cassette located in the targeting vector (pKOS 73). 
Primers of the wild-type allele (wt-fw and wt-rv) and primers of the targeted 
allele (mut-fw and mut-rv) are shown. (b) Genomic DNA was isolated for 
genotyping of the offspring mice. PCR analysis detected fragments of the 
Slc10a1 wild-type (412-bp) and targeted (624-bp) alleles. Homozygous wild-
type (+/+) mice, as well as heterozygous (+/-) or homozygous knockout (-/-) 
male and female mice are shown. All PCR products were separated by 1.0% 
agarose gel electrophoresis. (c) Slc10a1 mRNA expression in female and 
male wild-type (WT), heterozygous (HET) and Slc10a1-/- (KO) mouse livers, 
analyzed by qRT-PCR. Slc10a1 expression values were calculated relative to 
the geometric mean of Rplp0 and Tbp and normalized to male wild-type mice 
(set at 1.0). Data are represented as mean ± S.E.M. from 6-7 male (light grey) 
or female mice (dark grey). Asterisk indicates p-value below 0.05. (d) NTCP 
protein levels (~45-50 kDa) in liver plasma membranes of WT and KO male 
mice (n=3), analyzed by Western blot. Equal volumes of protein were loaded, 
as confirmed by the sodium/potassium ATPase (~90 kDa). (e) 
Immunofluorescent NTCP staining in WT and KO fresh frozen liver tissue. 
Scale bar is 40 µm. 
 
Figure 2: (A) TCA uptake assay in primary hepatocytes of wild-type (WT) and 
Slc10a1-/- (KO) mice. TCA uptake was performed after pre-incubation for 30 
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minutes in sodium-containing buffer (Na, black bar), sodium-free buffer 
(NMDG, light grey bar), sodium-containing buffer plus 1 µM Myrcludex B (Na 
+ Myr B, dark grey bar) and sodium-free buffer plus 1 µM Myrcludex B 
(NMDG + Myr B, white bar). Bars represent the mean ± S.E.M. for 2 
independent experiments,  each performed in triplicate. Asterisk indicates p-
value below 0.05. (B) Total serum BA concentrations in male and female wild-
type (WT) and Slc10a1-/- (KO) mice. Data are given as mean ± S.E.M on a 
10log scale for 7-16 mice in each group, quantified using the total BA assay. 
Serum composition of (C) conjugated and (D) unconjugated BA species as 
quantified using HPLC. Wild-type (white bars), Slc10a1-/- mice with normal 
(light grey bars), and Slc10a1-/- mice with high serum BA concentrations (dark 
grey bars) are shown. Conjugated BAs (C-BA) concentrations are the sum of 
TαMCA, TβMCA, TUDCA, TCA, TCDCA and TDCA. Unconjugated BAs (U-
BA) concentrations are the sum of ωMCA, αMCA, βMCA, CA, UDCA, CDCA 
and DCA. Data are given as mean ± S.E.M on a 10log scale for 3-6 mice in 
each group. Asterisk indicates p-value below 0.05 (compared to wild-type 
levels). (E) Serum BA composition of wild-type, Slc10a1-/- mice with normal, 
and KO mice high serum BA concentrations. Conjugated BA (dark grey) and 
unconjugated BA (light grey) species are shown as a percentage of total, as 
quantified using HPLC. (F) Total serum BA levels in relation to body weights 
of WT (open dots) and KO (black dots) 8-week-old mice (n=11-14).  
 
Figure 3: Effects of BA supplementation on serum BA concentrations. After 4 
days of 0.1% UDCA-supplementation, serum composition of (A) conjugated 
and (B) unconjugated BA species was measured in 5-week-old wild-type 
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(open dots) and Slc10a1-/- mice (black dots). Data are given as a scatter plot 
on a 10log scale from 5 mice in each group. Asterisk indicates p-value below 
0.05. (C) Total serum BA levels were measured before starting 0.1% UDCA-
supplementation (pre-UDCA), and after 1 week (post-UDCA) in 8-10-week-old 
Slc10a1-/- mice (black dots). As a control total serum BA levels of wild-type 
mice (open dots) were measured after 0.1% UDCA-supplementation. Data 
are given on a 10log scale from 4 wild-type and 8 Slc10a1-/- mice. 
 
Figure 4: (A) In vivo serum TCA clearance and (B) cumulative biliary 
excretion in wild-type (open dots) and normocholanemic (black dots) Slc10a1-
/- mice. TCA kinetics after an intravenous TCA bolus (150 µmol/kg BW) are 
given as a percentage of the whole bolus (=100%). Serum and bile kinetics 
are given as the mean ± S.E.M. (2 - 40 minutes post-injection, n=5). Mice 
were considered normocholanemic if total BA concentration was <20 µM 
before the start of the experiment. Cross symbol indicates death. (C) Total 
serum BA (TBA) clearance during hypercholanemia. TBA concentrations from 
4 hypercholanemic Slc10a1-/- mice are given relative to the concentration at 
the start of gall bladder cannulation (set at 100%).  
 
Figure 5: Effects of NTCP deficiency on the enterohepatic circulation. Bile 
was collected for 30 minutes after gall bladder cannulation and ligation of the 
common bile duct. (A) Bile flow (µL/min/100g BW) is shown during this period 
for wild-type (open dots), normocholanemic (black dots) and hypercholanemic 
(black triangles) Slc10a1-/- mice. (B) Bile acid output (nmol/min/100g BW) 
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during the 10 - 20 minute collection period for wild-type (white bar), 
normocholanemic Slc10a1-/- (light grey bar) and hypercholanemic Slc10a1-/- 
mice (dark grey bar). Data is given as mean ± S.E.M. (n=8-12). (C) Total fecal 
BA excretion (µmol/24h/kg BW) and (D) relative mRNA expression of BA 
transporters in the distal ileum for wild-type mice (white bars), Slc10a1-/- mice 
with low (light grey bars) and high (dark grey bars) serum BA concentrations, 
using the geometric mean of control genes Hprt and Ppib. (E) Urinary BA 
concentrations (µM) and (F) relative mRNA expression of renal BA 
transporters for wild-type (white bars), Slc10a1-/- mice with low (light grey 
bars) and high (dark grey bars) serum BA concentrations, using the geometric 
mean of control genes Rplp0 and Hprt. Data (in C-F) is given as mean ± 
S.E.M. (n=4-6) from 6-8 week-old mice. Asterisk indicates p-value below 0.05 
(compared to wild-type levels). 
 
Figure 6: (A) Oatp mRNA expression as determined by RT-qPCR. Relative 
mRNA expression levels were calculated for wild-type mice (white bars), 
Slc10a1-/- mice with low (light grey bars) and high (dark grey bars) serum BA 
concentrations using the geometric mean of control genes Rplp0 and Tbp.  
Both sexes were pooled equally. Values are given as mean ± S.E.M. for 4-6 
mice per group. (B) Western blot analysis of the OATP1B2 (~80 kDa), 
OATP1A1 and OATP1A4 (both ~85 kDa) proteins. Protein expression levels 
were determined relative to the sodium/potassium ATPase (~90 kDa) and 
values are given as mean ± S.E.M. for 4-5 mice per group. Asterisk indicates 
p-value below 0.05 (compared to wild-type levels). 
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Figure 7: Myrcludex B-derived peptide binding assessed by microPET. (A) 
Female wild-type (+/+, first panel), heterozygous (+/-, second panel) and 
homozygous Slc10a1-/- (-/-, third panel) mice were imaged post-injection of 
68Ga-WT peptide or 68Ga-control peptide (fourth panel). Top: Uncorrected 
planar projection, bottom: coronal PET section. (B) Time activity curves of 
68Ga-WT peptide (as SUV BW) in liver and kidney of wild-type (black line with 
dots), heterozygous (blue line with squares) and Slc10a1-/- (red line with 
triangles) male mice during 60 minutes post-injection.  
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Table 1: Body weight development of wild-type (WT) and all Slc10a1-/- (KO) mice. 
Male and female body weights are shown (n=7-17 per group). Values are given as 
mean ± S.E.M. Asterisk indicates p-value below 0.05. 
Body weights Unit WT KO p-value 
Males (2-3 week old) grams 6.6 ± 0.6 7.0 ± 0.6 0.71 
           (5-6 week old) grams 21.0 ± 0.8 13.6 ± 1.6 0.001* 
           (8-9 week old)   grams 24.6 ± 0.9 19.9 ± 1.4 0.02* 
Females (2-3 week old) grams 7.7 ± 0.6 7.0 ± 0.6 0.41 
               (5-6 week old) grams 17.3 ± 0.4 14.7 ± 0.7 0.02* 
               (8-9 week old)  grams 20.4 ± 0.4 17.8 ± 0.8 0.03* 
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68Ga-WT peptide (myr-K(68Ga-DOTA)-HBVpreS3-48y)
68Ga-control peptide (myr-K(68Ga-DOTA)-HBVpreS3-48y Ala11-15)
KTNLSVPNP LGFFP DHQLDPAFGANSNNPDWDFNPNKDHWPEANKVGy
KTNLSVPNP AAAAA DHQLDPAFGANSNNPDWDFNPNKDHWPEANKVGy
3                            11         15                                                                                                                                  48
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Supplementary materials & methods 
Gene-targeting strategy and generation of Slc10a1-/- mice 
Mice heterozygously lacking exon 1 of Slc10a1 were generated by Lexicon Genetics 
Incorporated (The Woodlands, Texas, US), and obtained via Taconic (Hudson, NY, US). 
Exon 1 of Slc10a1 was replaced using a targeting vector consisting of 5’ (7.7-kb) and 3’ (1.3-
kb) sequence homology arms flanking a β-galactosidase/puromycin (βgeo/puro) selection 
cassette, as shown in figure 1A. Experiments were performed on 6 to 10 week-old Slc10a1-/- 
male and female mice using littermate controls, unless stated otherwise. All mice were kept 
on a 12h light-dark cycle and received a standard chow (SDS, Witham, England) and water 
ad libitum. In one experiment, 0.1% (w/w) ursodeoxycholic acid (UDCA; Sigma-Aldrich) was 
supplemented to standard chow for 4-8 days. The study design and all protocols for animal 
care and handling were approved by the Institutional Animal Care and Use Committee of the 
University of Amsterdam.  
 
RNA isolation and qRT-PCR 
Total RNA was isolated from approximately 50 mg of liver, terminal ileum and kidney with 
TRIzol reagent (Invitrogen, Bleiswijk, The Netherlands). RNA integrity was assessed by 
agarose gel electrophoresis and spectrophotometrically at 260 nm using a Nanodrop 1000 
(Thermo Scientific, Wilmington, US). Five-hundred nanograms of total RNA were treated 
with DNAse (Promega, Madison, US) and first-strand cDNA was synthesized with Oligo-
dT12-18 and Superscript II reverse transcriptase (Invitrogen). Quantitative real-time PCR 
(qRT-PCR) was carried out in a Roche Lightcycler 480 II instrument using SensiFAST SYBR 
No-ROX kit (Bioline, UK) and was analysed using LinRegPCR 12.5 software. Expression 
levels in each sample were normalized for the geometrical mean of two reference genes 
(supplementary table 2 shows qPCR primer sequences). 
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Western Blot analysis 
Crude mouse liver membranes were isolated by pestle homogenization on ice in hypotonic 
lysis buffer (10 mM KCl, 1.5 mM MgCl2, 10 mM Tris-HCl pH 7.4) supplemented with 
protease inhibitor cocktail (Complete, Roche, Mannheim, Germany). Liver homogenates 
were subjected to ultracentrifugation (200,000 x g, 45 minutes) and the pellets were 
resuspended in RIPA buffer (50 mM Tris-HCl, pH 8.0, 150 mM NaCl, 1% (v/v) NP-40, 0.5% 
(w/v) Na-deoxycholate, 0.1% (w/v) SDS). Samples were treated with PNGase F according to 
the manufacturer’s protocol (New England Biolabs), with the exception that denaturation of 
the samples was performed at 37 °C for 5 min. Membrane proteins (50 µg/lane) were 
separated on a 10% SDS-polyacrylamide electrophoresis gel, transferred to nitrocellulose 
and probed with rabbit anti-mouse NTCP or anti-rat OATP1A1 (kind gifts of B. Stieger, 
Zürich, Switzerland), anti-mouse OATP1A4 (Santa Cruz: sc-18436), or anti-mouse 
OATP1B2 (kind gift of R. B. Kim, London, Canada) antibodies. As a positive control for 
NTCP, U2OS cells (human bone osteosarcoma epithelial cells) stably transfected with 
hNTCP-HA were analysed by Western blot, as previously described (1).  Equal loading was 
ensured by reprobing the membrane with an anti-sodium/potassium ATPase antibody (kind 
gift of J. Koenderink, Nijmegen, the Netherlands) or with an anti-β-actin antibody (Abcam; 
ab8226). Immune complexes were detected with a horseradish peroxidase-conjugated 
secondary antibody (Biorad), visualized using enhanced chemiluminescence detection 
reagent (Lumi-light, Roche) and detected using ImageQuant LAS 4000 (GE Healthcare). 
Densitometry was performed in ImageJ software. 
 
Histology and immunohistochemistry 
Livers were fixed in 4% PFA overnight, dehydrated in 70% ethanol, and paraffin-embedded. 
For routine histological tissue examination, hematoxylin-eosin stainings were investigated in 
wild-type and Slc10a1-/- mice. For specific NTCP staining, small cubes of fresh frozen liver 
tissue were embedded in OCT (Agar Scientific), and 7 µm cryosections were fixed in 100% 
acetone for 10 minutes. Slides were blocked with 5% (v/v) normal goat serum in PBS + 
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0.05% (v/v) tween-20 (blocking buffer) for 1 hour, followed by incubation with rabbit anti-
mouse NTCP antibody in blocking buffer for 1 hour. After washings, the slides were 
incubated with goat anti-rabbit Alexa 568 IgG. Images were captured with a Leica SP8X 
confocal microscope. 
 
Primary hepatocyte isolation and sandwich culture 
Primary mouse hepatocytes (PMHs) were isolated from wild-type and Slc10a1-/- mice by a 2-
step collagenase perfusion method. The liver was perfused through the portal vein with Ca2+-
free Krebs/Henseleit-bicarbonate buffer (pH 7.4) saturated with O2/CO2 (95:5 v/v) at 37 °C 
for 10 min, followed by perfusion for an additional 10 min with 20 mg collagenase type IV 
(0.5 mg/mL) and CaCl2 (1.7 μmol/L). The softened liver was transferred to a sterile plastic 
dish, and cells were dispersed with a coarse comb in Ca2+-containing Krebs/Henseleit-
bicarbonate buffer (pH 7.4), and filtered through nylon gauze. The filtrate was washed and 
centrifuged three times 3 min at 60 x g, with a final wash in buffer containing 1% (w/v) BSA. 
Routinely, 30-40 million cells were obtained with viability of at least 85%, as determined by 
trypan blue exclusion. Next, cells were plated in Dulbecco’s modified Eagle’s medium 
(DMEM) supplemented with 2 mM L-glutamine, 100 U/L penicillin/streptomycin and 5% FCS 
at 250,000 cells per well in 24-wells plates pre-coated with rat-tail collagen type I (1,5 mg/ml, 
pH 7.4, BD Biosciences). After 3 hours for attachment at 37 °C, a second collagen layer was 
added to obtain a sandwich configuration, as described by Annaert (2), and cells were 
cultured another hour in DMEM supplemented with 2 mM L-glutamine and 100 U/L 
penicillin/streptomycin.  
 
Taurocholic acid uptake assay 
After a 30-minute pre-incubation at 37 °C in sodium-containing uptake buffer (136 mM NaCl, 
5 mM KCl, 1.1 mM KH2PO4, 1 mM MgCl2, 1.8 mM CaCl2, 10 mM D-Glucose, 10 mM 
HEPES, pH 7.4) with and without Myrcludex B (1 μM), PMHs were incubated at 37 °C for 1 
minute with uptake buffer containing 10 μM TCA of which a trace amount (0.1 μM) was 
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tritium-labelled ([3H]TCA, Perkin Elmer, Groningen, The Netherlands). To assess sodium-
dependence of the TCA uptake, NaCl was replaced with equimolar N-methyl-D-glucamine 
(NMDG). Cells were washed four times with ice-cold PBS buffer and lysed with milliQ water 
containing 0.05% (w/v) SDS. Radioactivity in the lysates was measured by liquid scintillation 
counting. Data are presented of two independent PMH isolations, each condition performed 
in triplicate. All values for TCA uptake were corrected for nonspecific binding by subtracting 
signal determined in control dishes without cells.  
 
Quantification of bile acids 
Feces were collected (24 h) from individually housed mice (to avoid coprophagy), lyophilized 
and weighed. The dried stools were homogenized and BAs were extracted in 50% (v/v) t-
butanol (Merck). Total BA concentrations in feces, urine and serum were quantified with the 
Total Bile Acid Assay kit (Diazyme Laboratories, Poway, US) by measuring absorbance at 
410 nm using a NOVOstar analyzer (BMG-Labtech, Offenburg, Germany). Concentrations of 
different BA species in serum were determined by reverse-phase HPLC. For HPLC, serum 
was deproteinized by adding dropwise 5 volumes of acetonitrile (Biosolve, Valkenswaard, 
The Netherlands), followed by vortex-mixing, centrifugation at 12,000 x g for 10 min and 
vacuum-drying of the supernatant. Serum BAs were solubilized in 25% methanol. 100 µl was 
applied to a Hypersil C18 (3 µm, 15 cm HPLC column, Thermo Scientific, Breda, The 
Netherlands). Starting eluent consisted of 6.8 mM ammonium formate (pH 3.9), followed by 
several steps of linear gradients to different concentrations of acetonitrile (Biosolve, 
Valkenswaard, The Netherlands). Detection was performed using a Nano Quantity Analyte 
Detector QT-500 (Quant technologies, Blaine, US). Quantification of the different BA species 
was performed using calibration curves for all BA species.  
 
Bile secretion and TCA elimination in vivo 
To investigate bile secretion in fasted Slc10a1-/- mice, gall bladder cannulation and bile 
collection was performed. Bile was collected in aliquots every 10 minutes for 30 minutes 
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after distal ligation of the common bile duct, as described in (3). Bile flow was determined 
gravimetrically assuming a density of 1 g/mL for bile. Bile output was the calculated as the 
product of the bile flow and the bile concentration in the second 10-minute collection period. 
After the 30 minutes depletion-phase, a single bolus of 150 µmol TCA / kg mouse (including 
a trace amount of tritium-labelled TCA) was administered intravenously in the tail vein in 100 
µL 0.9% NaCl per 20 g mouse. A heating pad maintained body temperature at 37 °C. Blood 
samples (~30 µL) were collected at 30 minutes before TCA administration and both blood 
and bile were collected at the indicated time points after TCA administration. Radioactivity in 
serum and bile was measured by liquid scintillation counting, and values are shown as a 
percentage of the total bolus (=100%). During the gall bladder cannulation experiment 
without prior TCA administration, blood was collected directly before bile collection. 
 
Peptide synthesis, 68Ga-labelling and PET-imaging 
Myrcludex B-derived myristoylated HBV preS1 peptides were synthesized on a solid phase 
matrix using fluorenylmethoxycarbonyl/t-butyl (Fmoc/tBu) chemistry, as previously described 
(4). For selective coupling of DOTA to the N-terminal lysine side chain on the solid phase, 
the building block Fmoc-Lys(Aloc)-OH was used. After myristoylation the Aloc orthogonal 
protecting group was selectively removed and the peptide was reacted with DOTA-DFP, as 
previously described (5). Following cleavage from the resin, the peptides were purified using 
preparative high-pressure liquid chromatography (HPLC) and analysed by mass 
spectrometry (WT-peptide myr-K(DOTA)HBVpreS3-48y; m/zcalculated: 6015.9283; m/zobserved: 
6016.0201; control-peptide myr-K(DOTA)HBVpreS3-48y Ala11-15; m/zcalculated: 5809.8188; 
m/zobserved: 5809.9182). Peptides are depicted schematically in supplementary figure 4. For 
68Ga-labelling, 1000 µl [68Ga]Ga3+ eluate, 20 µl of a 1 mM peptide solution in DMSO, 10 µl 
ascorbic acid solution (20% in H2O) and 295 µl 2.5 M sodium acetate were mixed (pH 3.6) 
and heated at 90 °C for 15 minutes. The labelled product was purified using solid phase 
extraction (Thermo Scientific, Schwerte, Germany). The peptide was eluted from the 
cartridge with 2 ml ethanol. The ethanol was evaporated, the peptide dissolved in 60 µl 
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DMSO and 240 µl of 0.9% NaCl were added. The solution was filtered with a 0.22 µM sterile 
filter prior to injection. Mice were anesthetized with 1% sevoflurane (Abbott, Wiesbaden, 
Germany) and placed into an Inveon small animal PET scanner (Siemens, Knoxville, US) in 
a prone position. Investigators were blinded to mouse genotypes. A dynamic microPET was 
performed up to 60 min post-injection with 68Ga-labelled peptides (6 to 27 MBq/animal in a 
100 µl peptide solution in a tail vein). For pretesting of the peptides, female NMRI mice 6 to 
8 weeks of age were injected with 68Ga-labelled peptides and static images were taken from 
60-80 min post-injection. 
 
Statistical analysis 
Data are provided as the mean ± standard error of the mean. Differences between groups 
were analysed using 2-tailed Student’s t-test. For serum and bile kinetics, half-time (t1/2) and 
one-phase decay curves were calculated using Graphpad Prism 5. Statistical significance 
was considered at p <0.05. 
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Supplementary tables and figures 
 
Supp. table 1: Primer sequences used for amplification of the mouse Slc10a1 gene by 
polymerase chain reaction (PCR). 
Gene name       Sense and antisense    Product length 
Slc10a1 (wild-type allele)     5’-CATCTGACCAGCATTGAGGC-3’           412-bp  
     5’-GTTCTGAGGAACTCTTTCATC-3’     
 Slc10a1 (targeted allele)    5’-GGTCTCCGAGACTGAGCTAG-3’           624-bp  
    5’-CCCTAGGAATGCTCGTCAAGA-3’     
 
Supp. table 2: Oligonucleotide primers used for qRT-PCR analysis of wild-type and 
Slc10a1-/- (each used at a final concentration of 5 µM). Genes of interest are involved in 
hepatic sinusoidal BA uptake (Slc10a1, Slco1a1, Slco1a4, Slco1b2), intestinal and renal BA 
transport (Slc10a2, Slc51a and Abcc2). Reference genes (Rplp0, Tbp, Ppib and Hprt) are 
also shown. 
Gene name       Sense and antisense Product length Used in 
Slc10a1 5’-TGGCTACCTCCTCCCTGATG-3’ 380-bp Liver 
 5’-GCCAGGTTGTGTAGGAGGAT-3’   
Slco1a1 5’-TGAGAAAGACAGCAGTAGGACTTT-3’ 162-bp Liver 
 5’-GTGATTTGGCTAGGTATGCAC-3’   
Slco1a4 5’-TACATGTCAGCTTGCCTCGC-3’ 140-bp Liver 
 5’-GCACACTCAGGACCCTTGTC-3’   
Slco1b2 5’-GGGTGAATGCCCAAGAGACA-3’ 282-bp Liver 
 5’-TATAGCCTGCATGCTCCACG-3’   
Slc10a2 5'-CCATGGGGTATCTTCGTGGG-3' 278-bp Ileum, kidney 
 5'-GTTCCCGAGTCAACCCACAT-3'   
Slc51a 5'-GGCATCTATGACCCAGGAGA-3' 151-bp Ileum, kidney 
 5'-TGGATCCCATGTTCTGTTCA-3'   
Slc51b 5'-GACCACAGTGCAGAGAAAGC-3' 102-bp Liver 
 5'-ATTCCAAGGAGCCGCATCT-3'   
Abcc2 5'-AGCAGGTGTTCGTTGTGTGT-3' 133-bp Kidney 
 5'-AGCCAAGTGCATAGGTAGAGAAT-3'   
Rplp0 5’-CCAGCGAGGCCACACTGCTG-3’ 169-bp Liver, kidney 
 5’-ACACTGGCCACGTTGCGGAC-3’   
Tbp 5’-GGAGAATCATGGACCAGAACA-3’ 89-bp Liver 
 5’-GATGGGAATTCCAGGAGTCA-3’   
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Ppib 5'-TCGGAGCGCAATATGAAGGT-3' 65-bp Ileum 
 5'-AAAAGGAAGACGACGGAGCC-3'   
Hprt 5'-TTGCTCGAGATGTCATGAAGGA-3' 91-bp Ileum 
 5'-AGCAGGTCAGCAAAGAACTTATAG-3'   
 
Supp. table 3: Liver weights and biochemical indicators in serum of 2-month-old wild-type, 
normocholanemic and hypercholanemic Slc10a1-/- mice. Female mice were included (n=4-5 
per group). AST: aspartate aminotransferase. ALT: alanine aminotransferase. ALP: alkaline 
phosphatase. Values are given as mean ± S.E.M. Asterisk indicates p-value below 0.05. 
 
Supp. figure 1: (A) NTCP protein (~45-50 kDa) levels in liver membranes of wild-type (WT) 
and heterozygous (HET) Slc10a1 mice. Values are given as mean ± S.E.M., quantified 
relative to sodium/potassium ATPase (~ 90 kDa) and normalized to wild-type levels (set at 
1.0).  Liver membrane homogenate of one Slc10a1-/- (KO) mouse was included as negative 
control. (B) Mouse NTCP protein size without (-) and with (+) N-glycosidase PNGase F 
treatment (left panel). As a positive control, deglycosylation of HA-tagged hNTCP, stably 
transfected in U2OS cells, was shown by Western blot analysis (right panel). β-actin served 
as a loading control. 
 
Supp. figure 2: Liver hematoxylin-eosin histology comparing adult male wild-type and 
Slc10a1-/- mice. Both knockout mice with normal serum BAs and high serum BAs were 
investigated. Section thickness is 7 µm. Portal vein (pv) and central vein (cv) are indicated. 
Scale bar is 100 µm. 
Parameter Unit wild-type KO low BA KO high BA 
Liver weight % of body weight 5.2 ± 0.2 5.0 ± 0.2 5.2 ± 0.2 
Serum total bilirubin µmol/L 3.2 ± 0.7 7.2 ± 3.4 24.8 ± 7.5 * 
Serum conjugated bilirubin µmol/L 2.6 ± 0.6 8.2 ± 5.8 31.4 ± 8.0 * 
Serum AST U/L 142.5 ± 33.1 186.7 ± 43.6 896.4 ± 403.3 
Serum ALT U/L 58.0 ± 12.5 51.0 ± 15.8 152.8 ± 47.6 
Serum ALP U/L 22.0 ± 6.2 15.9 ± 4.6 219.1 ± 38.8 * 
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 Supp. figure 3: Relative mRNA expression levels of the Oatp-isoforms were calculated for 
wild-type and hypercholanemic Slc10a1-/- mice upon dietary supplementation with 0.1% 
UDCA. Values are given as mean ± S.E.M. for 4-6 adult female mice per group. Asterisk 
indicates p-value below 0.05. 
 
Supp. figure 4: (A) Schematic representation of 68Ga-WT peptide (top) and 68Ga-control 
peptide (bottom). (B) microPET-based pretesting of the Myrcludex-B-derived peptides in 
female wild-type NMRI mice. Top: Uncorrected planar projection, bottom: coronal PET 
section. 
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